DK0891371T3 - 9-oximsilylerythromycin A derivater - Google Patents

9-oximsilylerythromycin A derivater

Info

Publication number
DK0891371T3
DK0891371T3 DK97905826T DK97905826T DK0891371T3 DK 0891371 T3 DK0891371 T3 DK 0891371T3 DK 97905826 T DK97905826 T DK 97905826T DK 97905826 T DK97905826 T DK 97905826T DK 0891371 T3 DK0891371 T3 DK 0891371T3
Authority
DK
Denmark
Prior art keywords
derivatives
silylerythromycin
oxime
alkylerythromycin
oximesilyl
Prior art date
Application number
DK97905826T
Other languages
Danish (da)
English (en)
Inventor
Yi-Yin Ku
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24510750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0891371(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0891371T3 publication Critical patent/DK0891371T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97905826T 1996-04-02 1997-02-06 9-oximsilylerythromycin A derivater DK0891371T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/626,524 US5837829A (en) 1996-04-02 1996-04-02 9-oximesilyl erythromycin a derivatives
PCT/US1997/001955 WO1997036913A1 (en) 1996-04-02 1997-02-06 9-oximesilyl erythromycin a derivatives

Publications (1)

Publication Number Publication Date
DK0891371T3 true DK0891371T3 (da) 2004-04-13

Family

ID=24510750

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97905826T DK0891371T3 (da) 1996-04-02 1997-02-06 9-oximsilylerythromycin A derivater

Country Status (10)

Country Link
US (1) US5837829A (enExample)
EP (1) EP0891371B1 (enExample)
JP (2) JP2000507574A (enExample)
AT (1) ATE256138T1 (enExample)
CA (1) CA2250771C (enExample)
DE (1) DE69726714T2 (enExample)
DK (1) DK0891371T3 (enExample)
ES (1) ES2212808T3 (enExample)
PT (1) PT891371E (enExample)
WO (1) WO1997036913A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT915899E (pt) 1996-07-29 2004-11-30 Abbott Lab Preparacao da forma cristalina ii da eritromicina
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
ES2177448B1 (es) * 1997-12-22 2004-08-01 Biochemie S.A. "oxima de eritromicina a.".
KR100283990B1 (ko) * 1998-12-29 2001-03-02 민경윤 에리스로마이신 a 유도체 및 그의 제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB9915745D0 (en) * 1999-07-06 1999-09-08 Biochemie Sa Organic compounds
CZ20021999A3 (cs) * 1999-12-16 2003-02-12 Teva Pharmaceutical Industries Ltd. Způsob přípravy klaritromycinových polymorfních forem a nového polymorfu IV
CA2397092A1 (en) 2000-01-11 2001-07-19 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
KR100367981B1 (ko) * 2000-11-23 2003-01-14 한미약품공업 주식회사 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물
DE60122791T2 (de) * 2000-03-15 2007-10-04 Hanmi Pharm. Co., Ltd. Verfahren zur Herstellung von Clarythromycin mit nicht pharmazeutischer Qualität
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
EP1663169A4 (en) 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
ES2498040T3 (es) 2007-07-27 2014-09-24 Janssen Alzheimer Immunotherapy Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법

Also Published As

Publication number Publication date
PT891371E (pt) 2004-04-30
CA2250771C (en) 2006-05-02
US5837829A (en) 1998-11-17
JP2007224035A (ja) 2007-09-06
DE69726714D1 (en) 2004-01-22
JP2000507574A (ja) 2000-06-20
WO1997036913A1 (en) 1997-10-09
CA2250771A1 (en) 1997-10-09
EP0891371A1 (en) 1999-01-20
ES2212808T3 (es) 2004-08-01
EP0891371B1 (en) 2003-12-10
ATE256138T1 (de) 2003-12-15
DE69726714T2 (de) 2004-10-07

Similar Documents

Publication Publication Date Title
PT891371E (pt) Derivados 9-oxima-sililo da eritromicina a
ES2191982T3 (es) Derivados de 6-o-alquilo de eritronolida b.
AU591564B2 (en) 5-acylamino-pyrazole derivatives
AU7596587A (en) Benzimidazole derivatives
ES2191821T3 (es) Procedimiento de preparacion de oxima de eritromicina a.
AU6853987A (en) Produce hydration system
PT1042340E (pt) Oxima de 6-o-alquil-eritromicina b
TR199500917A2 (tr) Iiia grubunun organometalik türevleri ve bunlarin hazirlanisi icin bir islem.
AU7067087A (en) Improved process for preparing macrolide derivatives
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
DK555289A (da) Fermenteringsfremgangsmaade
AU7827687A (en) Macrolide derivatives
FI904259A7 (fi) Epipodofyllotoksiinialtrosidijohdannaisia
AU7703887A (en) Tube expander
DK445188A (da) Vandoploeseligt antibiotisk praeparat
KR970702922A (ko) 독소루비신의 제조방법(Process for preparing doxorubicin)
AU8204887A (en) Conjugate vaccine
AU7216287A (en) Benzimidazole derivatives
NO901071L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
DE3888529D1 (de) Tylosinderivate und Verfahren zu ihrer Herstellung.
AU3665289A (en) Polysilazanes, process for their preparation
EP0549597A4 (en) Anionic furanose derivatives, methods of making and using the same
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
DE68910125D1 (de) Oral-Präparate.
AU7382887A (en) Fabric repair system